Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402324 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 202
- Enrollment target
NCT00402324 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 202 participants.
The verdict
NCT00402324, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 202 participants
- Enrollment target
Study Summary
Whether treatment with olanzapine in combination with mood stabilizer reduces symptoms of both mania and depression more than treatment with mood stabilizer alone, in patients with a mixed episode of bipolar I disorder.
Interventions
- DRUG placebo
- DRUG olanzapine
- DRUG divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2006-12 |
| Est. Completion | 2008-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402324
The ClinicalTrials.gov registry entry for NCT00402324 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00402324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402324 about?
NCT00402324 is a clinical study titled "A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients". Whether treatment with olanzapine in combination with mood stabilizer reduces symptoms of both mania and depression more than treatment with mood stabilizer alone, in patients with a mixed episode of bipolar I disorder.
What is the current status of trial NCT00402324?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 202 participants. The study started on 2006-12. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00402324?
The interventions under investigation include: placebo (DRUG), olanzapine (DRUG), divalproex (DRUG).
Who is sponsoring clinical trial NCT00402324?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.